Bone impairment in phenylketonuria is characterized by circulating osteoclast precursors and activated T cell increase.
about
Bone health in phenylketonuria: a systematic review and meta-analysisGenetically engineered probiotic for the treatment of phenylketonuria (PKU); assessment of a novel treatment in vitro and in the PAHenu2 mouse model of PKULow bone strength is a manifestation of phenylketonuria in mice and is attenuated by a glycomacropeptide diet.Cross-talk between T cells and osteoclasts in bone resorption.Triptolide Inhibits Osteoclast Differentiation and Bone Resorption In Vitro via Enhancing the Production of IL-10 and TGF-β1 by Regulatory T Cells.Pathogenesis of Bone Alterations in Gaucher Disease: The Role of Immune System.Peripheral Blood Mononuclear Cells Spontaneous Osteoclastogenesis: Mechanisms Driving the Process and Clinical Relevance in Skeletal Disease.Inflammation induces osteoclast differentiation from peripheral mononuclear cells in chronic kidney disease patients: crosstalk between the immune and bone systems.Impact of Dietary Intake on Bone Turnover in Patients with Phenylalanine Hydroxylase Deficiency.Constitutional bone impairment in Noonan syndrome.Generation of urine-derived induced pluripotent stem cells from a patient with phenylketonuria.Critical illness-related bone loss is associated with osteoclastic and angiogenic abnormalitiesImpact of pregnancy on inborn errors of metabolism
P2860
Q27008288-293A61B5-BAAB-4FA7-B3F4-879031245036Q33698843-C590B115-4A03-4CB6-90C3-A8841C667A81Q34428243-6F88E2AE-734C-484D-9D95-FE3F646D592AQ37056309-95B9CA3D-BD83-4D04-BEAC-57F17D61FD53Q37060097-21534274-9879-4BDC-989B-0AC373A2AD68Q38524847-93F503EB-9D45-4ED8-9A63-5D85E8963B5FQ38568957-FA7648CF-9FF1-404B-9E27-A748A085EDD6Q41921500-D6FA1E5A-0065-4D2C-B61D-AB6915242654Q47116443-06B55279-8F38-4612-B53E-79465CD595A2Q52905410-00F85D92-A457-4F24-B0B7-FB48B877D294Q55187124-F53B516A-5029-4075-91D1-85DB275C44B3Q57245218-F7AE9151-B628-4C73-8E08-7204538E3268Q58752732-34F5F4E0-5D72-42B4-BCBB-989CB6AFFACC
P2860
Bone impairment in phenylketonuria is characterized by circulating osteoclast precursors and activated T cell increase.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Bone impairment in phenylketon ...... and activated T cell increase.
@ast
Bone impairment in phenylketon ...... and activated T cell increase.
@en
type
label
Bone impairment in phenylketon ...... and activated T cell increase.
@ast
Bone impairment in phenylketon ...... and activated T cell increase.
@en
prefLabel
Bone impairment in phenylketon ...... and activated T cell increase.
@ast
Bone impairment in phenylketon ...... and activated T cell increase.
@en
P2093
P2860
P50
P1433
P1476
Bone impairment in phenylketon ...... and activated T cell increase.
@en
P2093
Davide Garelli
Lucia D'Amico
Ludovica Fiore
Marco Spada
Riccardo Ferracini
P2860
P304
P356
10.1371/JOURNAL.PONE.0014167
P407
P577
2010-11-30T00:00:00Z